Delivery Order SPE2DB20D1100-SPE2DB24FA1H3
Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $341,640.00 firm-fixed-price delivery order is for the supply of 4532067832 units of Glyburide 5mg tablets, a medication used to treat diabetes. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary...
- This federal contract award is for the delivery of Glyburide 5 mg tablets in quantities of 1,000 to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,245.80 and was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,172.03, is a delivery order for 4,567,908,472 units of the drug glyburide 5 mg tablets. The contract is a firm fixed-price arrangement with an ultimate completion date of April 15, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors....
- This federal contract award, with ID SPE2DX15D6041|SPE2DX24FBVHD, is a delivery order for the supply of 4,564,741,574 units of the pharmaceutical drug Glyburide 5 mg tablets. The award, with a ceiling value of $2,526.54, was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. Amerisourcebergen, a major pharmaceutical distribution company, has significant experience supplying medical products and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glyburide 5 mg tablets in quantities of 1,000 units, valued at $3,236.58. This award, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed price delivery order with no set-aside designation. The contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $2,461.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Glyburide 5 mg tablets (100-count units). This is a non-set-aside competitive award with a completion date of October 24, 2025, and performance at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,431.41 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Glyburide 5 mg tablets in a quantity of 500 units. This is a firm fixed-price, non-set-aside contract with performance scheduled for completion by September 26, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Glyburide is a sulfonylurea medication commonly used in the treatment of type 2 diabetes mellitus. This...
- This federal contract award, valued at $5,889.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4566370509 - GLYBURIDE-METFORMIN 5-500 MG 100S, a pharmaceutical product. The contract has an ultimate completion date of November 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,247.78 firm fixed-price delivery order is for the supply of Glimepiride 4 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,803.08 Firm Fixed Price delivery order is for the supply of Glyburide-Metformin 5-500 mg medication, with a performance period through May 25, 2023. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...